About Evaluate Group
Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus sales forecasts to 2022. We support life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making.
Evaluate has a global presence with offices in the UK, USA and Japan.
Our services include EvaluatePharma, EvaluateClinical Trials and EvaluateMedTech. Our global team of dedicated healthcare analysts employs rigorous methodologies to deliver strategic commercial analysis.
We make our services valuable by combining superior quality content, user-friendly reporting tools and outstanding customer service to solve client problems.
Our award-winning editorial team, EP Vantage, leverages our market intelligence and analysis to cut through the noise, giving you daily opinion and insights. The Evaluate services enable the life science community to make sound business decisions about value and opportunity.
Evaluate has also been named as one of the Best Workplaces 2017, ranking at no. 38 of all UK Medium Organisations.